EP 1030911 A1 20000830 - HUMAN ASPARTIC PROTEASES
Title (en)
HUMAN ASPARTIC PROTEASES
Title (de)
MENSCHLICHE ASPARTAT-PROTEASEN
Title (fr)
PROTEASES ASPARTIQUES HUMAINES
Publication
Application
Priority
- US 9915988 W 19990715
- US 11664198 A 19980716
Abstract (en)
[origin: WO0004137A1] The invention provides human aspartic proteases (NHAP) and polynucleotides which identify and encode NHAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of NHAP.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61P 3/00 (2006.01); A61P 11/00 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); C07K 16/40 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 9/64 (2006.01); C12N 15/09 (2006.01); C12P 21/08 (2006.01); C12Q 1/68 (2006.01)
CPC (source: EP)
A61P 3/00 (2017.12); A61P 11/00 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); C12N 9/6478 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 0004137A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0004137 A1 20000127; WO 0004137 A9 20000608; AU 5213199 A 20000207; CA 2303062 A1 20000127; EP 1030911 A1 20000830; JP 2002520048 A 20020709
DOCDB simple family (application)
US 9915988 W 19990715; AU 5213199 A 19990715; CA 2303062 A 19990715; EP 99937257 A 19990715; JP 2000560235 A 19990715